Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-12 Purchase(A) |
2022-10-18 6:20 pm |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer |
38,500 | $2.0363 | $78,397 | 743,867 (Indirect Direct) |
View |
| 2020-11-06 Purchase |
2020-11-10 3:48 pm |
Lexaria Bioscience Corp. | LXRP | BUNKA CHRISTOPHER CEO 10% Owner |
195,500 | $0.20342 | $39,769 | 20,785,492 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-07 Option Award |
2025-01-10 11:52 am |
N/A N/A |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Director |
100,000 | $0 | 1,480,337 (Direct) |
View |
| 2024-04-26 Option Award |
2024-05-10 4:44 pm |
2024-04-26 2029-04-26 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer |
49,500 | $0 | 1,106,794 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 12:30 pm |
2023-10-26 2028-10-26 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer |
30,000 | $0 | 926,293 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 5:00 pm |
N/A N/A |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO |
21,900 | $1.988 | 1,011,204 (Indirect) |
View |
| 2022-10-13 Option Award |
2022-10-13 5:00 pm |
N/A N/A |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO |
16,600 | $2.1 | 1,011,204 (Indirect) |
View |
| 2022-08-29 Option Award |
2022-08-29 5:18 pm |
2022-08-29 2027-08-29 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer |
30,000 | $0 | 756,792 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-02 1:58 pm |
2021-09-01 2026-09-01 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO |
15,000 | $0 | 655,791 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 12:57 pm |
2021-06-08 2026-06-08 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO |
23,334 | $0 | 584,790 (Direct) |
View |
| 2021-05-07 Other |
2021-06-09 12:48 pm |
2020-04-23 2025-04-23 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO |
23,334 | $0 | 614,791 (Direct) |
View |
| 2021-04-26 Option Award |
2021-04-27 5:13 pm |
2021-04-26 2026-04-26 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO 10% Owner |
26,000 | $0 | 582,124 (Direct) |
View |
| 2020-05-06 Option Award |
2020-06-04 5:16 pm |
2020-05-06 2025-05-06 |
Lexaria Bioscience Corp. | LXRP | BUNKA CHRISTOPHER CEO 10% Owner |
200,000 | $0 | 14,308,148 (Indirect) |
View |
| 2020-05-06 Option Award |
2020-05-08 7:05 pm |
N/A N/A |
Lexaria Bioscience Corp. | LXRP | BUNKA CHRISTOPHER CEO 10% Owner |
200,000 | $0.23 | 20,189,992 (Indirect) |
View |